(2003; 211 pages)
1. TB - A Global Emergency. Geneva, World Health Organization, 1994 (document WHO/TB/94.177).
2. Global Tuberculosis Control: Surveillance, Planning, Financing. Geneva, World Health Organization, 2002 (WHO/CDS/TB/2002.295).
3. Grange J. The global burden of disease. In: Porter J, Grange J, eds. Tuberculosis: an international perspective. London, Imperial College Press, 1999.
4. Fox W, Gordon A, Mitchison D. Studies on the treatment of tuberculosis undertaken by the British Medical Research Council Tuberculosis Units, 1946 - 1986, with relevant publications. International Journal of Tuberculosis and Lung Diseases, 1999, 3: S231 - S270.
5. Fox W. The problem of self-administration of drugs: with particular reference to pulmonary tuberculosis. Tubercle, 1958, 39: 269 - 274.
6. Addington W. Patient compliance: The most serious remaining problem in the control of tuberculosis in the United States. Chest, 1979, 76: 741 - 743.
7. Urquhart J. Patient non-compliance with drug regimens: measurement, clinical correlates, economic impact. European Heart Journal, 1996, 17 (Suppl A): 8 - 15.
8. Volmink J, Garner P. Interventions for promoting adherence to tuberculosis management. Cochrane Database of Systematic Reviews, 2000, (4): CD000010.
9. Urquhart J. Ascertaining how much compliance is enough with outpatient anti-biotic regimens. Postgraduate Medical Journal, 1992, 68: 49 - 59.
10. Sumartojo E. When tuberculosis treatment fails. A social behavioral account of patient adherence. American Review of Respiratory Disease, 1993, 147: 1311 - 1320.
11. Trostle JA. Medical compliance as an ideology. Social Science & Medicine, 1988, 27: 1299 - 1308.
12. Liefooghe R et al. Perception and social consequences of tuberculosis: a focus group study of tuberculosis patients in Sialkot, Pakistan. Social Science & Medicine, 1995, 41: 1685 - 1692.
13. Hudelson P. Gender differentials in tuberculosis: the role of socio-economic and cultural factors. Tubercle & Lung Disease, 1996, 77: 391 - 400.
14. Farmer P. Social inequalities and emerging infectious diseases. Emerging Infectious Diseases, 1996, 2: 259 - 269.
15. Diwan VK, Thorson A. Sex, gender, and tuberculosis. Lancet, 1999, 353: 1000 - 1001.
16. Dick J, Lombard C. Shared vision - a health education project designed to enhance adherence to anti-tuberculosis treatment. International Journal of Tuberculosis & Lung Disease, 1997, 1: 181 - 186.
17. Banerji D. A social science approach to strengthening India's national tuberculosis programme. Indian Journal of Tuberculosis, 2002, 40: 61 - 82.
18. Treatment of Tuberculosis: guidelines for National Programmes. Geneva, World Health Organization, 1997(document WHO/TB/94.177).
19. Lewin SA et al. Interventions for providers to promote a patient-centred approach in clinical consultations. Cochrane Database Systematic Reviews, 2001, CD003267.
20. Steyn M et al. Communication with TB patients; a neglected dimension of effective treatment? Curationis, 1997, 20: 53 - 56.
21. Mushlin AI, Appel FA. Diagnosing potential noncompliance. Physicians' ability in a behavioral dimension of medical care. Archives of Internal Medicine, 1977, 137: 318 - 321.
22. Caron HS, Roth HP. Patients' cooperation with a medical regimen. Difficulties in identifying the noncooperator. Journal of the American Medical Association, 1968, 203: 922 - 926.
23. Davis MS. Predicting non-compliant behavior. Journal of Health & Social Behavior, 1967, 8: 265 - 271.
24. Dick J et al. Development of a health education booklet to enhance adherence to tuberculosis treatment. Tubercle & Lung Disease, 1996, 77: 173 - 177.
25. Bandura A. Social learning theory. Englewood Cliffs, NY, Prentice Hall, 1977.
26. Ajzen I, Fishbein M. Understanding attitudes and predicting social behavior. Englewood Cliffs, NY, Prentice Hall, 1980.
27. Green L, Krueter M. Health promotion planning: an educational and environmental approach. Mountainview, CA, Mayfield Publishing, 1991.
28. Health behavior and health education: theory, research, and practice. San Francisco, CA, Jossey-Bass, 1997.
29. Fisher JD, Fisher WA. Changing AIDS-risk behavior. Psychological Bulletin, 1992, 111: 455 - 474.
30. From the Centers for Disease Control and Prevention. Approaches to improving adherence to antituberculosis therapy. Journal of the American Medical Association, 1998, 269: 1096 - 1098.
31. Sbarbaro JA, Sbarbaro JB. Compliance and supervision of chemotherapy of tuberculosis. Seminars in Respiratory Infections, 1994, 9: 120 - 127.
32. Raviglione M, Pio A. Evolution of WHO policies for tuberculosis control, 1948 - 2001. Lancet, 2002, 359: 775 - 780.
33. Bayer R, Wilkinson D. Directly observed therapy for tuberculosis: history of an idea. Lancet, 1995, 345: 1545 - 1548 [erratum published in Lancet, 1995, 346: 322].
34. Bass JB, Jr. et al. Treatment of tuberculosis and tuberculosis infection in adults and children. American Thoracic Society and The Centers for Disease Control and Prevention. American Journal of Respiratory & Critical Care Medicine, 1994, 149: 1359 - 1374.
35. Chaulk CP, Kazandjian VA. Directly observed therapy for treatment completion of pulmonary tuberculosis: Consensus Statement of the Public Health Tuberculosis Guidelines Panel. Journal of the American Medical Association, 1998, 279: 943 - 948 [erratum published in Journal of the American Medical Association, 1998, 280: 134].
36. Enarson D et al. Management of tuberculosis: a guide for low income countries, 5th ed. Paris, International Union Against Tuberculosis and Lung Disease, 2000.
37. Maher D et al. Treatment of tuberculosis: guidelines for national programmes, 2nd ed. Geneva, World Health Organization, 1997.
38. Farmer P et al. Tuberculosis, poverty, and "compliance": lessons from rural Haiti. Seminars In Respiratory Infections, 1991, 6: 254 - 260.
39. Olle-Goig JE, Alvarez J. Treatment of tuberculosis in a rural area of Haiti: directly observed and non-observed regimens. The experience of Hôpital Albert Schweitzer. International Journal of Tuberculosis & Lung Disease, 2001, 5: 137 - 141.
40. Burman WJ et al. A cost-effectiveness analysis of directly observed therapy vs self-administered therapy for treatment of tuberculosis. Chest, 1997, 112: 63 - 70.
41. An Expanded DOTS Framework for Effective Tuberculosis Control. Geneva, World Health Organization, 2002 (document WHO/CDS/TB/2002.297).
42. Jin BW et al. The impact of intensified supervisory activities on tuberculosis treatment. Tubercle & Lung Disease, 1993, 74: 267 - 272.
43. Liefooghe R et al. A randomised trial of the impact of counselling on treatment adherence of tuberculosis patients in Sialkot, Pakistan. International Journal of Tuberculosis & Lung Disease, 1999, 3: 1073 - 1080.
44. Pilote L et al. Tuberculosis prophylaxis in the homeless. A trial to improve adherence to referral. Archives of Internal Medicine, 1996, 156: 161 - 165.
45. Malotte CK, Rhodes F, Mais KE. Tuberculosis screening and compliance with return for skin test reading among active drug users. American Journal of Public Health, 1998, 88: 792 - 796.
46. Paramasivan R, Parthasarathy R, Rajasekaran S. Short course chemotherapy: A controlled study of indirect defaulter retrieval method. Indian Journal of Tuberculosis, 1993, 40: 185 - 190.
47. Tanke ED, Martinez CM, Leirer VO. Use of automated reminders for tuberculin skin test return. American Journal of Preventive Medicine, 1997, 13: 189 - 192.
48. Krishnaswami KV et al. A randomised study of two policies for managing default in out-patients collecting supplies of drugs for pulmonary tuberculosis in a large city in South India. Tubercle, 1981, 62: 103 - 112.
49. Volmink J, Garner P. Directly observed therapy for treating tuberculosis. Cochrane Database of Systematic Reviews. 2001 (4): CD003343.
50. Suarez PG et al. The dynamics of tuberculosis in response to 10 years of intensive control effort in Peru. The Journal of Infectious Diseases, 2001, 184: 473 - 478.
51. Fujiwara PI, Larkin C, Frieden TR. Directly observed therapy in New York City. History, implementation, results, and challenges. Clinics In Chest Medicine, 1997, 18: 135 - 148.
52. Results of directly observed short-course chemotherapy in 112,842 Chinese patients with smear-positive tuberculosis. China Tuberculosis Control Collaboration. Lancet, 1996, 347: 358 - 362.
53. Tulsky JP et al. Adherence to isoniazid prophylaxis in the homeless: a randomized controlled trial. Archives of Internal Medicine, 2000, 160: 697 - 702.
54. White MC et al. A clinical trial of a financial incentive to go to the tuberculosis clinic for isoniazid after release from jail. International Journal of Tuberculosis & Lung Disease, 1998, 2: 506 - 512.
55. Salleras SL et al. Evaluation of the efficacy of health education on the compliance with antituberculosis chemoprophylaxis in school children. A randomized clinical trial. Tubercle & Lung Disease, 1993, 74: 28 - 31 [erratum published in Tubercle & Lung Disease, 1993, 74: 217].
56. Morisky DE et al. A patient education program to improve adherence rates with antituberculosis drug regimens. Health Education Quarterly, 1990, 17: 253 - 267.